Multiple Sclerosis, Disease-Modifying Therapies, and Infections-Reference-Cited by-同舟云学术

Multiple Sclerosis, Disease-Modifying Therapies, and Infections

Published:2023-11 Issue:6 Volume:10 Page:
ISSN:2332-7812
Container-title:Neurology Neuroimmunology & Neuroinflammation
language:en
Short-container-title:Neurol Neuroimmunol Neuroinflamm

Author:

Langer-Gould Annette M.¹,Smith Jessica B.¹,Gonzales Edlin G.¹,Piehl Fredrik¹^ORCID,Li Bonnie H.¹

Affiliation:

1. From the Department of Neurology (A.M.L.-G.), Los Angeles Medical Center, Southern California Permanente Medical Group; Department of Research and Evaluation (J.B.S., E.G.G., B.H.L.), Southern California Permanente Medical Group, Pasadena; and Department of Clinical Neuroscience (F.P.), Karolinska Institute, Stockholm, Sweden.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Neurology

Link

https://www.neurology.org/doi/pdfdirect/10.1212/NXI.0000000000200164

Reference22 articles.

1. Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

2. Assessing and mitigating risk of infection in patients with multiple sclerosis on disease modifying treatment

4. Infections in patients diagnosed with multiple sclerosis: A multi-database study

5. Infections in patients with multiple sclerosis: A national cohort study in Sweden

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting multiple sclerosis disease progression and outcomes with machine learning and MRI-based biomarkers: a review;Journal of Neurology;2024-09-12

2. Hospitalisations and humoral COVID-19 vaccine response in vaccinated rituximab-treated multiple sclerosis patients;Multiple Sclerosis and Related Disorders;2024-09

3. Data-driven risk/benefit estimator for multiple sclerosis therapies;2024-08-17

4. MS treatment de-escalation: review and commentary;Journal of Neurology;2024-08-02

5. De-escalation and Discontinuation of Disease-Modifying Therapies in Multiple Sclerosis;Current Neurology and Neuroscience Reports;2024-07-12